Status:
UNKNOWN
Heart Rate Monitoring by Wearable Devices in Graves' Disease
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Graves' Disease in Remission (Disorder)
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
A multi center randomized controlled study including 3 arms (wearable device group, control group 1, control group 2). This study is to investigate clinical feasibility of heart rate monitoring using ...
Detailed Description
A multi center randomized controlled study including 3 arms (wearable device group, control group 1, control group 2). Study participants: Patients with Graves' disease who are planned to discontinue...
Eligibility Criteria
Inclusion
- Patients with Graves' disease who are being treated with anti-thyroid drugs (ATDs) and planned to discontinue ATDs
- Those who have who have continued to administer ATDs for more than 1 year
- Those who showed normal findings on thyroid function tests while maintaining stable doses of ATDs in the last 3 months
- Those who can use wearable devices and smartphone apps to work with during the research period
Exclusion
- Those with heart disease, such as arrhythmia, that can affect heart rate
- Those who are taking medications that may affect their heart rate
- Those who researchers deemed unsuitable for participation
Key Trial Info
Start Date :
November 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04333342
Start Date
November 22 2019
End Date
December 31 2023
Last Update
April 13 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Chungbuk National University Hospital
Cheongju-si, South Korea
2
Chung-Ang University Hospital
Seoul, South Korea
3
Eulji University Nowon Eulji Medical Center
Seoul, South Korea
4
Korea University Guro Hospital
Seoul, South Korea